1-(5-isoquinolinesulfonyl)piperazine has been researched along with h 89 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aherne, GW; Bavetsias, V; Berdini, V; Caldwell, J; Collins, I; Davies, TG; Davis, D; Donald, A; Fonseca, T; Garrett, MD; Hunter, LJ; McDonald, E; Rowlands, MG; Seavers, LC; Woodhead, SJ; Workman, P; Wyatt, PG | 1 |
| Gerena, L; Geyer, JA; Keenan, SM; Waters, NC; Welsh, WJ; Woodard, CL | 1 |
2 other study(ies) available for 1-(5-isoquinolinesulfonyl)piperazine and h 89
| Article | Year |
|---|---|
Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B.
Topics: Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Cyclic AMP-Dependent Protein Kinases; Drug Design; Humans; Isoquinolines; Ligands; Molecular Structure; Protein Kinase C; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Structure-Activity Relationship; Sulfonamides | 2006 |
Evaluation of broad spectrum protein kinase inhibitors to probe the architecture of the malarial cyclin dependent protein kinase Pfmrk.
Topics: Animals; Binding Sites; Crystallography, X-Ray; Cyclic AMP-Dependent Protein Kinases; Cyclin-Dependent Kinases; Drug Evaluation, Preclinical; Enzyme Inhibitors; Inhibitory Concentration 50; Ligands; Malaria; Molecular Conformation; Naphthalenes; Plasmodium falciparum; Sulfonamides | 2007 |